Literature DB >> 21823075

High prevalence of obesity in young patients with ST elevation myocardial infarction.

Abhijeet Basoor1, John F Cotant, Gagan Randhawa, Muhammad Janjua, Aaref Badshah, Michele DeGregorio, Abdul R Halabi, Benjamin Diaczok, Kiritkumar C Patel, Paul Stein.   

Abstract

BACKGROUND: There is growing concern about increasing rates of obesity in young people, and increasing ST elevation myocardial infarction (STEMI) at a younger age. There are only a few studies performed to study the risk factors in STEMI among young populations.
METHODS: Retrospective chart reviews on all first event STEMI patients between December 2005 and July 2007 were performed. A young population was defined as: men <45 years of age and women <55 years of age.
RESULTS: Among 206 patients with STEMI, 36 were young. In young patients with STEMI, 78 % were obese compared with 35 % obese, non-young (p<0.001). Also, among young patients with STEMI, family history of coronary heart disease (CHD) was positive in 39 %, compared with 19 % in non-young patients (p=0.009). This significance for obesity and family history persisted after adjusting for other risk factors using logistic regression (OR 2.96 to 17.75, 95 % CI, p<0.0001 and OR 1.36 to 7.47, 95 % CI, p=0.008, respectively).
CONCLUSION: Obesity and family history of CHD were major risk factors with a higher prevalence in young patients with STEMI than non-young patients.

Entities:  

Mesh:

Year:  2011        PMID: 21823075     DOI: 10.15420/ahhj.2011.9.1.37

Source DB:  PubMed          Journal:  Am Heart Hosp J        ISSN: 1541-9215


  3 in total

1.  No Racial Disparities in the Treatment of ST Elevation Myocardial Infarction - A Community-based Experience.

Authors:  Abhijeet Basoor; Gagan Randhawa; John F Cotant; Nishit Choksi; Abdul R Halabi; Kiritkumar C Patel; Michele DeGregorio
Journal:  Interv Cardiol       Date:  2013-08

2.  Comparison of Mortality Outcomes in Acute Myocardial Infarction Patients With or Without Standard Modifiable Cardiovascular Risk Factors.

Authors:  Ching-Hui Sia; Junsuk Ko; Huili Zheng; Andrew Fu-Wah Ho; David Foo; Ling-Li Foo; Patrick Zhan-Yun Lim; Boon Wah Liew; Ping Chai; Tiong-Cheng Yeo; James W L Yip; Terrance Chua; Mark Yan-Yee Chan; Jack Wei Chieh Tan; Gemma Figtree; Heerajnarain Bulluck; Derek J Hausenloy
Journal:  Front Cardiovasc Med       Date:  2022-04-14

3.  Butyrylcholinesterase predicts cardiac mortality in young patients with acute coronary syndrome.

Authors:  Patrick Sulzgruber; Lorenz Koller; Thomas Reiberger; Feras El-Hamid; Stefan Forster; David-Jonas Rothgerber; Georg Goliasch; Johann Wojta; Alexander Niessner
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.